Supply Chain Featured Articles
-
Pharmaceutical Cold Chain: A Major Concern For The Unknown
6/18/2015
Pharmaceutical products are the most vulnerable during transport. Maintaining the cGDP quality system for transportation and product protection is a difficult challenge, and coupled with the increased focus on high-growth protein products that are environmentally sensitive, the concerns during transportation are heightened for several reasons.
-
What Is the Industry Underestimating About An ADC Supply Chain? – Part 2
3/27/2015
In this article, Dan Bell, vice president of regulatory compliance and technical affairs for Marken, discusses regulatory challenges, and both he and Nathan Ihle, Ph.D., VP of CMC Strategy and Management at Seattle Genetics, offer best practices to apply when planning your ADC supply chain.
-
Why Pharmaceutical Companies Should Manage S&OP In The Cloud
3/18/2015
With continuously changing regulations, the rise of over-the-counter and generic products, and the shift from local to global supply chains, pharmaceutical manufacturers are gaining a greater understanding of the value of sales and operations planning (S&OP).
-
Lo Jack SCI Partnership Integrates Cold Chain Solutions
4/10/2014
Maintaining a product’s quality throughout shipment is a challenge in any industry, but delivering pharmaceuticals in the cold chain can be especially challenging because of the consequences related to temperature excursion. For this reason, Ted Wlazlowski, CEO and president of LoJack SCI, a company specializing in cargo and freight security, believes it’s necessary to offer clients both strategic planning and security for their cold chain shipments. And through their recent partnership with Modality, a supply chain environmental assessment and engineering solutions company, this is now possible.
-
Introducing Cold Chain Manager - Unique Technology For Clinical Trial And Drug Development Shipments
11/1/2013
Quick's IT team has made another innovative upgrade to our online customer platform (QuickOnlineRx) to help monitor temperature-sensitive shipments. By Eric Bischoff, Chief Information Technology Officer, Quick International Courier
-
Global Supply Chain Creates Increased Challenges For Life Science Companies
10/8/2013
There is no question the life science industry is global in nature. Numerous pharma companies have locations in multiple countries and across multiple continents. According to its web site, Pfizer alone has offices in 45 different countries. Many of those firms now have suppliers, as well as CMO and CRO partners, that are also stretched across multiple continents. That extended global supply chain has made the job of the folks who handle the shipping of drugs and materials to those varied locations ever more complicated.
-
Marine Transportation Becomes Feasible For Pharmaceuticals
7/9/2013
Ocean shipping has long been the transportation mode of choice for low cost goods with long shelf lives. Items that were high value, high tech or had limited shelf lives were shipped air cargo or, once on the continent, by truck or train. That is beginning to change. Now, even pharmaceutical manufacturers and logistics providers are exploring ocean shipping for all or part of a journey.
-
Why Life Science Companies Need An Agile And Reliable Supply Chain
6/24/2013
Limited supply chain agility increases the odds that your company will not be able to respond adequately and rapidly enough to changing market conditions or competitive moves. At best, a less reliable supply chain puts supply continuity at risk; at worst, it puts patient safety at hazard. Ernst & Young’s recent Growing Beyond survey reveals that there are clear differences in how leaders and laggards are mobilizing to address those issues. By Jamie Hintlian of Ernst & Young
-
9 Steps To Remember When Performing A Supply Chain Risk Assessment
This article provides practical tools for creating a risk assessment procedure related to Good Distribution Practice (GDP) guidelines.
-
Web Connected Biologistics: Cold Chain Lessons Learned From Pharma
Shipping a drug product – particularly one that is both time-and temperature-sensitive – is only the beginning of a long and circuitous journey where the variety of potential threats and challenges increases and risks to product quality are heightened the further the product travels from its origin.